Vacc-4x shows statictically significant reduction in viral load

Further analysis of Vacc-4x phase IIb study shows a statistically significant reduction in viral load over placebo – Bionor Pharma reverses decision to put Vacc-4x on hold After further analyses of the international, randomized, double-blind, placebo-controlled multi-center phase IIb study of Bionor Pharma’s therapeutic HIV-vaccine candidate, Vacc-4x, the Company reports an unexpected statistically significant reduction …

Read more